3.4 Read 9 reviews
Overview
This Immuno-oncology course offered by Harvard Medical School Online explores the relationship between cancer and the immune system, examining how immune cells identify, attack, and eliminate malignant cells. Participants develop an understanding of tumor immunology and the biological mechanisms that influence immune responses against cancer. The programme highlights advances that have transformed cancer treatment and demonstrates how immune system knowledge is being leveraged to improve patient care.
Key Facts
Learners investigate immune recognition, T-cell and natural killer cell responses, mechanisms of tumor immune evasion, and the factors influencing therapeutic effectiveness. The course covers checkpoint blockade therapies, CAR T-cell approaches, bispecific T-cell engagers, tumor vaccines, oncolytic viruses, combination treatment strategies, and emerging immunotherapeutic developments. Clinical examples are used to illustrate the application of these approaches across different cancer types.
Programme Structure
Courses include:
- Basic Tumor Immunology
- Biology of Cancer
- Immune Recognition of Tumors
- CD8+ T Cell Responses
- CD4+ T Cell Responses
- Natural Killer Cell Responses
- Tumor Immune Evasion
- Checkpoint Blockade Mechanisms
- Checkpoint Blockade Therapy in Melanoma
Key information
Duration
- Part-time
- 3 months
Start dates & application deadlines
- Starting
- Apply before
-
- Starting
- Apply before
-
Language
English
Delivered
Online
Campus Location
- Boston, United States
Disciplines
Immunology View 8 other Short Courses in Immunology in United StatesWhat students do after studying
Join for free or log in to access our complete career info list.
Academic requirements
We are not aware of any specific GRE, GMAT or GPA grading score requirements for this programme.
English requirements
We are not aware of any English requirements for this programme.
Other requirements
General requirements
This course builds on foundational science by exploring complex concepts through engaging biomedical visualizations, clinical applications, and real-world scenarios. Participants are recommended to have prior knowledge of basic biology and immunology to gain the greatest benefit from the material.
- The course is suitable for scientists working in immunology, oncology, and related research fields who seek clinical perspectives on cancer treatment using immunological approaches. It is also appropriate for clinicians and other medical professionals interested in the mechanisms of the immune response to cancer and current immunotherapy strategies, as well as healthcare industry and research professionals seeking a comprehensive understanding of cancer immunology and its clinical applications.
Tuition Fees
Tuition fees are shown in and the most likely applicable fee is shown based on your nationality.
-
International Applies to you
Applies to youNon-residents1025 USD / full≈ 1025 USD / full - Out-of-State1025 USD / full≈ 1025 USD / full
-
Domestic
Applies to youIn-State1025 USD / full≈ 1025 USD / full
Funding
Improve page content